Charles River announces divestitures, updates guidance
Source: SeekingAlpha
2026-02-25 07:35:46 ET
More on IQVIA, Charles River Laboratories
- Charles River Laboratories International, Inc. (CRL) Q4 2025 Earnings Call Transcript
- Charles River Laboratories Q4 Review: Approaching A Bottom
- Charles River Laboratories International, Inc. 2025 Q4 - Results - Earnings Call Presentation
- Charles River projects up to 9% EPS growth in 2026 as new CEO, acquisitions, and cost savings drive margin expansion
- Charles River Laboratories beats top-line and bottom-line estimates; initiates FY26 outlook
Read the full article on Seeking Alpha
For further details see:
Charles River announces divestitures, updates guidance
IQVIA Holdings Inc.
NASDAQ: IQV
IQV Trading
2.67% G/L:
$179.06 Last:
757,426 Volume:
$174.49 Open:
IQV Latest News
IQV Stock Data
$31,275,595,000
168,494,820
N/A
548
N/A
Biotechnology & Life Sciences
Healthcare
US
Durham
